{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:48:43Z","timestamp":1782535723941,"version":"3.54.5"},"reference-count":61,"publisher":"Oceanside Publications Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    A penicillin allergy label increases the risk of hospitalization, length of hospital stays, and even mortality rate. This recognition has led to recommendations for proactive evaluation of penicillin allergy and de-labeling efforts. Less is known about the impact\n of the sulfonamide allergy label (SAL), the second-most-common antibiotic allergy label, on morbidity and mortality of patients and the impact on the health-care system. Further, the approach to patients with an SAL is not well characterized.\n                    <jats:bold>Objective:<\/jats:bold>\n                    We aimed to review\n recent evidence that examined the association between an SAL and clinical outcomes, including health-care utilization. We also aimed to review the evolving approach to an SAL, including the incorporation of decision tools and identifying patient populations that may benefit from proactive\n evaluation.\n                    <jats:bold>Methods:<\/jats:bold>\n                    We performed a narrative review of the literature.\n                    <jats:bold>Results:<\/jats:bold>\n                    There is increasing evidence that supports a negative impact for having an SAL on clinical outcomes. An SAL influences antibiotic prescription practices and is associated\n with an increased risk of opportunistic infections and urinary tract infections among recipients of solid organ transplantation and a small increase in the risk of complications from cystitis. The recent development and validation of the clinical decision tool, trimethoprim-sulfamethoxazole\n allergy clinical decision rule (SULF-FAST), and the proven feasibility and safety for direct oral challenge present an opportunity to offer proactive evaluation of individuals who might benefit from sulfonamide antibiotics such as individuals who are immunosuppressed, patients with recurrent\n urinary tract infections, or those with multiple antibiotic allergies.\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Proactive evaluation and de-labeling of sulfonamide allergy through direct oral challenge with trimethoprim-sulfamethoxazole could be considered in patients who are immunocompromised, patients\n with recurrent acute cystitis, and those with multiantibiotic allergy. Further research is needed to identify systematic hospital-wide interventions and to elucidate the benefit of such de-labeling on clinical outcomes.\n                  <\/jats:p>","DOI":"10.2500\/aap.2026.47.260019","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:42:02Z","timestamp":1777437722000},"page":"177-183","source":"Crossref","is-referenced-by-count":1,"title":["Should we follow the penicillin allergy label trail in approaching patients with a sulfonamide allergy label?"],"prefix":"10.2500","volume":"47","author":[{"given":"Samantha R.","family":"Horn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisoo","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Al-Shaikhly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/bcp.13830","article-title":"Antibiotic allergy labels in hospitalized and critically ill adults: a review of current impacts of inaccurate labelling","volume":"85","author":"Moran","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"B2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1592\/phco.31.8.742","article-title":"Impact of an antimicrobial allergy label in the medical record on clinical outcomes in hospitalized patients","volume":"31","author":"Charneski","year":"2011","journal-title":"Pharmacotherapy"},{"key":"B3","doi-asserted-by":"crossref","first-page":"1519522","DOI":"10.3389\/fphar.2024.1519522","article-title":"Association between penicillin allergy labels and serious adverse events in hospitalized patients: a systematic review and meta-analysis","volume":"15","author":"Zhang","year":"2025","journal-title":"Front Pharmacol"},{"key":"B4","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/j.jaip.2022.08.027","article-title":"Penicillin allergy label is associated with worse clinical outcomes in bacterial pneumonia","volume":"10","author":"Kaminsky","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B5","doi-asserted-by":"crossref","first-page":"k2400","DOI":"10.1136\/bmj.k2400","article-title":"Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study","volume":"361","author":"Blumenthal","year":"2018","journal-title":"BMJ"},{"key":"B6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2500\/aap.2025.46.250037","article-title":"Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization","volume":"46","author":"Waters","year":"2025","journal-title":"Allergy Asthma Proc"},{"key":"B7","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.jaip.2023.03.018","article-title":"Impact of penicillin allergy label on clinical outcomes of pneumonia in children","volume":"11","author":"Kaminsky","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.anai.2023.09.013","article-title":"Outcomes of acute pyelonephritis in patients with a penicillin allergy label in the United States","volume":"132","author":"Al-Obaydi","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/cid\/ciy037","article-title":"The impact of reported beta-lactam allergy in hospitalized patients with hematologic malignancies requiring antibiotics","volume":"67","author":"Huang","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/SLA.0000000000003949","article-title":"The effect of beta-lactam allergy status on the rate of surgical site infections: a retrospective cohort study","volume":"275","author":"Wilhelm","year":"2022","journal-title":"Ann Surg"},{"key":"B11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1542\/hpeds.2020-001636","article-title":"A Multidisciplinary quality improvement initiative to facilitate penicillin allergy delabeling among hospitalized pediatric patients","volume":"11","author":"Bauer","year":"2021","journal-title":"Hosp Pediatr"},{"key":"B12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/cid\/cix244","article-title":"Impact of an integrated antibiotic allergy testing program on antimicrobial stewardship: a multicenter evaluation","volume":"65","author":"Trubiano","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B13","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1016\/j.jaip.2023.09.045","article-title":"Penicillin allergy evaluation should be performed proactively in patients with a penicillin allergy label","volume":"11","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B14","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou","year":"2016","journal-title":"Allergy"},{"key":"B15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1592\/phco.26.4.551","article-title":"Sulfonamide allergies and outcomes related to use of potentially cross-reactive drugs in hospitalized patients","volume":"26","author":"Hemstreet","year":"2006","journal-title":"Pharmacotherapy"},{"key":"B16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/DHPS.S347522","article-title":"Clinical manifestations and genetic influences in sulfonamide-induced hypersensitivity","volume":"14","author":"Asyraf","year":"2022","journal-title":"Drug Healthc Patient Saf"},{"key":"B17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0002-9343(90)90337-D","article-title":"A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis","volume":"89","author":"Fox","year":"1990","journal-title":"Am J Med"},{"key":"B18","doi-asserted-by":"crossref","first-page":"ofx232","DOI":"10.1093\/ofid\/ofx232","article-title":"Sulfamethoxazole-trimethoprim (cotrimoxazole) for skin and soft tissue infections including impetigo, cellulitis, and abscess","volume":"4","author":"Bowen","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"B19","doi-asserted-by":"crossref","first-page":"e103\u2013e120","DOI":"10.1093\/cid\/cir102","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B20","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"e14355","DOI":"10.1111\/tid.14355","article-title":"Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients - a retrospective matched cohort study","volume":"26","author":"Al-Shaikhly","year":"2024","journal-title":"Transpl Infect Dis"},{"key":"B22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/imj.70057","article-title":"Impact of sulfonamide allergy label on clinical outcomes of acute cystitis: a retrospective matched cohort study","volume":"55","author":"Moussa","year":"2025","journal-title":"Intern Med J"},{"key":"B23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s41030-024-00260-4","article-title":"Impact of sulfonamide allergy label on clinical outcomes in patients with Pneumocystis jirovecii pneumonia","volume":"10","author":"Stone","year":"2024","journal-title":"Pulm Ther"},{"key":"B24","doi-asserted-by":"crossref","first-page":"e14410","DOI":"10.1111\/tid.14410","article-title":"Alternative pneumocystis pneumonia prophylaxis in solid organ transplants","volume":"27","author":"He","year":"2025","journal-title":"Transpl Infect Dis"},{"key":"B25","doi-asserted-by":"crossref","first-page":"e70063","DOI":"10.1111\/tid.70063","article-title":"Impact of pretransplant antimicrobial sulfonamide allergy label in kidney transplant recipients","volume":"27","author":"Powers","year":"2025","journal-title":"Transpl Infect Dis"},{"key":"B26","first-page":"8839805","article-title":"Donor-derived disseminated toxoplasmosis in a liver transplant recipient with documented sulfa allergy","volume":"2024","author":"Raglow","year":"2024","journal-title":"Case Rep Transplant"},{"key":"B27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/10600280241302412","article-title":"Evaluation of the incidence of Nocardia infection in solid organ transplant recipients on trimethoprim-sulfamethoxazole for opportunistic infection prophylaxis","volume":"59","author":"Jung","year":"2025","journal-title":"Ann Pharmacother"},{"key":"B28","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.1016\/j.ajt.2025.07.556","article-title":"Sulfonamide antibiotic allergy in solid organ transplant: defining the impact and identifying opportunities for de-labeling","volume":"25","author":"Hu","year":"2025","journal-title":"Am J Transplant"},{"key":"B29","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1399-0012.2009.01129.x","article-title":"Lower risk of urinary tract infection with low-dose trimethoprim\/sulfamethoxazole compared to dapsone prophylaxis in older renal transplant patients on a rapid steroid-withdrawal immunosuppression regimen","volume":"24","author":"Giullian","year":"2010","journal-title":"Clin Transplant"},{"key":"B30","doi-asserted-by":"crossref","first-page":"e14067","DOI":"10.1111\/ctr.14067","article-title":"Higher risk of urinary tract infections in renal transplant recipients receiving pentamidine versus trimethoprim-sulfamethoxazole (TMP-SMX) for pneumocystis pneumonia prophylaxis","volume":"34","author":"Fu","year":"2020","journal-title":"Clin Transplant"},{"key":"B31","doi-asserted-by":"crossref","first-page":"e0112922","DOI":"10.1128\/aac.01129-22","article-title":"Antibiotic-specific risk for community-acquired Clostridioides difficile infection in the United States from 2008 to 2020","volume":"66","author":"Zhang","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"B32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.anai.2025.09.008","article-title":"Risk factors and challenge outcomes in trimethoprim-sulfamethoxazole hypersensitivity in HIV-negative patients: a multicenter retrospective report","volume":"136","author":"Kinate","year":"2026","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B33","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s11606-019-04991-y","article-title":"Recorded penicillin allergy and risk of mortality: a population-based matched cohort study","volume":"34","author":"Blumenthal","year":"2019","journal-title":"J Gen Intern Med"},{"key":"B34","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1111\/all.14437","article-title":"Lymphocyte transformation test can be useful for the diagnosis of delayed adverse reactions to sulfonamides","volume":"75","author":"V\u00edlchez-S\u00e1nchez","year":"2020","journal-title":"Allergy"},{"key":"B35","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/all.14062","article-title":"Assessment of drug causality in Stevens-Johnson syndrome\/toxic epidermal necrolysis: concordance between lymphocyte transformation test and ALDEN","volume":"75","author":"Bell\u00f3n","year":"2020","journal-title":"Allergy"},{"key":"B36","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12125","article-title":"A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions","volume":"168","author":"Barbaud","year":"2013","journal-title":"Br J Dermatol"},{"key":"B37","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1016\/j.jaip.2025.05.056","article-title":"Utility of IFN-\u03b3 enzyme-linked immunospot as adjunctive diagnostic for severe T cell-mediated reactions to cotrimoxazole in high HIV and tuberculosis settings","volume":"13","author":"Selim","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0753-3322(00)88640-0","article-title":"The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. C.I.S.A.I. Group","volume":"54","author":"Bonfanti","year":"2000","journal-title":"Biomed Pharmacother"},{"key":"B39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0091-6749(03)01783-4","article-title":"Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics","volume":"112","author":"Empedrad","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B40","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/0091-6749(91)90186-R","article-title":"Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine","volume":"88","author":"Gruchalla","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"B41","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.jaip.2024.06.047","article-title":"Delayed skin testing for systemic medications: helpful or not?","volume":"12","author":"Barbaud","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/cod.14692","article-title":"Patch testing in non-immediate hypersensitivity to cotrimoxazole: is it useful?","volume":"91","author":"Soares","year":"2024","journal-title":"Contact Dermatitis"},{"key":"B43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tox.2004.12.024","article-title":"Drug patch testing in systemic cutaneous drug allergy","volume":"209","author":"Barbaud","year":"2005","journal-title":"Toxicology"},{"key":"B44","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/ijd.13306","article-title":"The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions","volume":"55","author":"Hassoun-Kheir","year":"2016","journal-title":"Int J Dermatol"},{"key":"B45","doi-asserted-by":"crossref","first-page":"AB8","DOI":"10.1016\/j.jaci.2024.12.028","article-title":"Performance of skin testing for delayed hypersensitivity reactions: importance of medications, concentrations and clinical phenotypes","volume":"155","author":"De Guzman Cejudo","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B46","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaip.2019.07.003","article-title":"Oral challenge with trimethoprim-sulfamethoxazole in patients with \u201csulfa\u201d antibiotic allergy","volume":"8","author":"Krantz","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2500\/aap.2020.41.190024","article-title":"Proactive management of penicillin and other antibiotic allergies","volume":"41","author":"Khan","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B48","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jaip.2024.05.046","article-title":"Decisions with patients, not for patients: shared decision-making in allergy and immunology","volume":"12","author":"Mack","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B49","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.jaip.2021.05.046","article-title":"The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy","volume":"9","author":"Rose","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B50","doi-asserted-by":"crossref","first-page":"e2519113","DOI":"10.1001\/jamanetworkopen.2025.19113","article-title":"International validation of the SULF-FAST risk-stratification tool for sulfonamide antibiotic allergy","volume":"8","author":"Stehlin","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B51","doi-asserted-by":"crossref","first-page":"e2316776","DOI":"10.1001\/jamanetworkopen.2023.16776","article-title":"Development and validation of a sulfa antibiotic allergy clinical decision rule","volume":"6","author":"Waldron","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B52","doi-asserted-by":"crossref","first-page":"147\u2013159","DOI":"10.1093\/cid\/ciu444","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B53","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.jaip.2019.05.051","article-title":"Beta-lactam and sulfonamide allergy testing should be a standard of care in immunocompromised hosts","volume":"7","author":"Trubiano","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B54","doi-asserted-by":"crossref","first-page":"e13885","DOI":"10.1111\/tid.13885","article-title":"Safety and value of pretransplant antibiotic allergy delabeling in a quaternary transplant center","volume":"24","author":"Gorsline","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"B55","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jaip.2020.09.010","article-title":"Safety, efficacy, and effectiveness of delabeling in patients with multiple drug allergy labels","volume":"9","author":"Vethody","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B56","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12879-016-1432-3","article-title":"The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study","volume":"16","author":"Singh","year":"2016","journal-title":"BMC Infect Dis"},{"key":"B57","doi-asserted-by":"crossref","first-page":"108732","DOI":"10.1016\/j.diabres.2021.108732","article-title":"Diabetes and acute bacterial skin and skin structure infections","volume":"174","author":"Falcone","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B58","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1542\/hpeds.2021-006369","article-title":"Feasibility of a centralized, pharmacy-led penicillin allergy delabeling program","volume":"12","author":"Antoon","year":"2022","journal-title":"Hosp Pediatr"},{"key":"B59","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaip.2022.08.052","article-title":"Comparative effectiveness, safety, and real-world outcomes of a nurse-led, protocol-driven penicillin allergy evaluation from the Hong Kong Drug Allergy Delabelling Initiative (HK-DADI)","volume":"11","author":"Kan","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2500\/aap.2021.42.200128","article-title":"Safety and efficacy of direct two-step penicillin challenges with an inpatient pharmacist-driven allergy evaluation","volume":"42","author":"Ham","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B61","doi-asserted-by":"crossref","first-page":"e219820","DOI":"10.1001\/jamanetworkopen.2021.9820","article-title":"Evaluation of a pharmacist-led penicillin allergy assessment program and allergy delabeling in a tertiary care hospital","volume":"4","author":"Turner","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2026\/00000047\/00000003\/art00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:44:53Z","timestamp":1782535493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2026.47.260019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5,1]]}},"alternative-id":["1088-5412(20260501)47:3L.177;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2026.47.260019","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}